title: Northern analysis of type II iodothyronine deiodinase mRNA in rat Harderian gland.
abstract: It has been known that type II iodothyronine deiodinase activity is present in rat Harderian gland and the activity is significantly increased by isoproterenol administration. We have performed Northern analyses to study whether the transcript for type II iodothyronine deiodinase is expressed in rat Harderian gland and whether the isoproterenol stimulation of type II iodothyronine deiodinase activity in rat Harderian gland is due to the change in its mRNA level. Northern analyses have demonstrated that type II iodothyronine deiodinase mRNA, approximately 7.5 kb in size, is expressed in rat Harderian gland, and the mRNA levels as well as the deiodinase activities are greater in hypothyroid rats than those in euthyroid rats. Type II iodothyronine deiodinase mRNA levels and the deiodinase activities in Harderian gland were increased by isoproterenol administration, and the increase in the mRNA levels preceded that in the deiodinase activities. These results indicate that 7.5 kb transcript for type II iodothyronine deiodinase is expressed in rat Harderian gland and beta-adrenergic stimulation of type II iodothyronine deiodinase activity is due at least in part to the increase in its mRNA level.
authors.affiliation: First Department of Internal Medicine, Gunma University School of Medicine, Japan.
authors.forename: O
authors.initials: O
authors.lastname: Araki
authors.forename: M
authors.initials: M
authors.lastname: Murakami
authors.forename: Y
authors.initials: Y
authors.lastname: Kamiya
authors.forename: Y
authors.initials: Y
authors.lastname: Hosoi
authors.forename: T
authors.initials: T
authors.lastname: Ogiwara
authors.forename: H
authors.initials: H
authors.lastname: Mizuma
authors.forename: T
authors.initials: T
authors.lastname: Iriuchijima
authors.forename: M
authors.initials: M
authors.lastname: Mori
mesh_terms: D000199:Actins / Q000235:genetics / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D013956:Antithyroid Agents / Q000633:toxicity; D015152:Blotting, Northern; D006243:Harderian Gland / Q000187:drug effects / Q000201:enzymology*; D007037:Hypothyroidism / Q000139:chemically induced / Q000378:metabolism; D007453:Iodide Peroxidase / Q000235:genetics* / Q000378:metabolism*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008713:Methimazole / Q000633:toxicity; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D000097564:Iodothyronine Deiodinase Type II
chemical_list: D000199:Actins; D000318:Adrenergic beta-Agonists; D013956:Antithyroid Agents; D007453:Iodide Peroxidase; D007545:Isoproterenol; D008713:Methimazole; D012333:RNA, Messenger; D000097564:Iodothyronine Deiodinase Type II